Pharming (PHAR) EBT Margin (2020 - 2026)

Pharming (PHAR) posted EBT Margin of 6.78% for Q1 2026, down 250.4% on a QoQ basis from 4.51% in Q4 2025, and up 213.0% year-over-year from 2.17% in Q1 2025.

Pharming (PHAR) EBT Margin (2020 - 2026) Analysis & Trends

Pharming's EBT Margin history runs 7 years deep, the most recent figure standing at 6.78% for Q1 2026.

  • Quarterly EBT Margin rose 213.0% year-over-year to 6.78% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.89% (up 1747.0% YoY) and the FY2025 annual result came in at 3.42%, up 627.0% from the prior year.
  • EBT Margin was 6.78% for Q1 2026 at Pharming, down from 4.51% in the prior quarter.
  • Across five years, EBT Margin topped out at 2024064.17% in Q3 2024 and bottomed at 14793103.45% in Q4 2023.
  • A 5-year average of 995389.41% and a median of 0.0% in 2025 frame the typical range for EBT Margin.
  • Annual changes were most pronounced in 2023 — EBT Margin slumped 1479312537 bps — and 2024, when it jumped 1064053621 bps.
  • Pharming's EBT Margin stood at 21.92% in 2022, then sank by 67485255 bps to 14793103.45% in 2023, then jumped by 72 bps to 4152567.24% in 2024, then surged by 100 bps to 4.51% in 2025, then plunged by 250 bps to 6.78% in 2026.
  • Business Quant data shows PHAR's EBT Margin at 6.78% in Q1 2026, 4.51% in Q4 2025, and 0.0% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Pharming 9.02 Bn 8.96 Bn 65.80 Mn -6.78%

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.78%
Dec 31, 2025 4.51%
Sep 30, 2025 0.00%
Jun 30, 2025 2.21%
Mar 31, 2025 -8.91%
Dec 31, 2024 -4,152,567.24%
Sep 30, 2024 2,024,064.17%
Jun 30, 2024 -14.99%
Mar 31, 2024 -29.35%
Dec 31, 2023 -14,793,103.45%
Sep 30, 2023 4.96%
Jun 30, 2023 -13.64%
Mar 31, 2023 -32.12%
Dec 31, 2022 21.92%
Sep 30, 2022 17.16%
Jun 30, 2022 35.53%
Mar 31, 2022 6.01%
Dec 31, 2021 -9.18%
Sep 30, 2021 -37.16%
Jun 30, 2021 21.86%